Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A
Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A - read this article along with other careers information, tips and advice on BioSpace
United States Dana Farber Cancer Institute Stanford University University Of California San Francisco Thomas Winkler Thomas Fuchs
Source: biospace.com